{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T11:52:14Z","timestamp":1793101934715,"version":"4.5.0"},"reference-count":83,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,5,3]],"date-time":"2022-05-03T00:00:00Z","timestamp":1651536000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003243","name":"Ministerstvo Zdravotnictv\u00ed Cesk\u00e9 Republiky","doi-asserted-by":"publisher","award":["023728"],"award-info":[{"award-number":["023728"]}],"id":[{"id":"10.13039\/501100003243","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003243","name":"Ministerstvo Zdravotnictv\u00ed Cesk\u00e9 Republiky","doi-asserted-by":"publisher","award":["NV18-01-00161A"],"award-info":[{"award-number":["NV18-01-00161A"]}],"id":[{"id":"10.13039\/501100003243","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001823","name":"Ministerstvo \u0160kolstv\u00ed, Ml\u00e1de\u017ee a Telov\u00fdchovy","doi-asserted-by":"publisher","award":["SVV 260523"],"award-info":[{"award-number":["SVV 260523"]}],"id":[{"id":"10.13039\/501100001823","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007543","name":"Grantov\u00e1 Agentura, Univerzita Karlova","doi-asserted-by":"publisher","award":["1578119"],"award-info":[{"award-number":["1578119"]}],"id":[{"id":"10.13039\/100007543","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Idiopathic inflammatory myopathies (IIM) are associated with systemic inflammation, limited mobility, and glucocorticoid therapy, all of which can lead to metabolism disturbances, atherogenesis, and increased cardiovascular (CV) risk. The aim of this study was to assess the CV risk in IIM patients and healthy controls (HC), and its association with disease-specific features.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Thirty nine patients with IIM (32 females; mean age 56; mean disease duration 4.8 years; dermatomyositis: <jats:italic>n<\/jats:italic> = 16, polymyositis: <jats:italic>n<\/jats:italic> = 7, immune-mediated necrotizing myopathy: <jats:italic>n<\/jats:italic> = 8, anti-synthetase syndrome: <jats:italic>n<\/jats:italic> = 8) and 39 age-\/sex-matched HC (32 females, mean age 56) without rheumatic diseases were included. In both groups, subjects with a history of CV disease (angina pectoris, myocardial infarction, cerebrovascular, and peripheral arterial vascular events) were excluded. Muscle involvement, disease activity, and tissue damage were evaluated (Manual Muscle Test-8, Myositis Intention to Treat Activity Index, Myositis Damage Index). Comorbidities and current treatment were recorded. All participants underwent examinations of carotid intima-media thickness (CIMT), pulse wave velocity (PWV), ankle-brachial index (ABI), and body composition (by densitometry and bioelectric impedance). The risk of fatal CV events was evaluated by the Systematic COronary Risk Evaluation (SCORE, charts for the European population) and its modifications.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Compared to HC, there was no significant difference in IIM patients regarding blood pressure, ABI, PWV, CIMT, and the risk of fatal CV events by SCORE or SCORE2, or subclinical atherosclerosis (CIMT, carotid plaques, ABI, and PWV). The calculated CV risk scores by SCORE, SCORE2, and SCORE multiplied by the coefficient 1.5 (mSCORE) were reclassified according to the results of carotid plaque presence and CIMT; however, none of them was demonstrated to be significantly more accurate. Other significant predictors of CV risk in IIM patients included age, disease duration and activity, systemic inflammation, lipid profile, lean body mass, and blood pressure.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>No significant differences in CV risk factors between our IIM patients and HC were observed. However, in IIM, CV risk was associated with age, disease duration, duration of glucocorticoid therapy, lipid profile, and body composition. None of the currently available scoring tools (SCORE, SCORE2, mSCORE) used in this study seems more accurate in estimating CV risk in IIM.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fmed.2022.861419","type":"journal-article","created":{"date-parts":[[2022,5,3]],"date-time":"2022-05-03T06:20:18Z","timestamp":1651558818000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":12,"title":["Cardiovascular Risk in Myositis Patients Compared to the General Population: Preliminary Data From a Single-Center Cross-Sectional Study"],"prefix":"10.3389","volume":"9","author":[{"given":"Sabina","family":"Oreska","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hana","family":"Storkanova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaroslav","family":"Kudlicka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vladimir","family":"Tuka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ondrej","family":"Mikes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zdislava","family":"Krupickova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Satny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Chytilova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Kvasnicka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maja","family":"Spiritovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbora","family":"Hermankova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petr","family":"Cesak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marian","family":"Rybar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karel","family":"Pavelka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ladislav","family":"Senolt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Herman","family":"Mann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiri","family":"Vencovsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michal","family":"Vrablik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michal","family":"Tomcik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,5,3]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1038\/nrrheum.2018.41","article-title":"Classification of myositis","volume":"14","author":"Lundberg","year":"2018","journal-title":"Nat Rev Rheumatol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1056\/NEJM197502132920706","article-title":"Polymyositis and dermatomyositis (first of two parts)","volume":"292","author":"Bohan","year":"1975","journal-title":"N Engl J Med."},{"key":"B3","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1056\/NEJM197502202920807","article-title":"Polymyositis and dermatomyositis (second of two parts)","volume":"292","author":"Bohan","year":"1975","journal-title":"N Engl J Med."},{"key":"B4","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1016\/j.nmd.2013.08.007","article-title":"188th ENMC International Workshop: Inclusion Body Myositis, 2-4 December 2011, Naarden, The Netherlands","volume":"23","author":"Rose","year":"2013","journal-title":"Neuromusc Disord."},{"key":"B5","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.nmd.2004.02.006","article-title":"119th ENMC international workshop: trial design in adult idiopathic inflammatory myopathies, with the exception of inclusion body myositis, 10-12 October 2003, Naarden, The Netherlands","volume":"14","author":"Hoogendijk","year":"2004","journal-title":"Neuromusc Disord."},{"key":"B6","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1038\/nrrheum.2018.48","article-title":"Risk factors and disease mechanisms in myositis","volume":"14","author":"Miller","year":"2018","journal-title":"Nat Rev Rheumatol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1111\/1756-185X.13309","article-title":"Atherosclerosis and autoimmunity: a growing relationship","volume":"21","author":"Sanjadi","year":"2018","journal-title":"Int J Rheum Dis."},{"key":"B8","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1016\/j.semarthrit.2014.12.002","article-title":"Cardiovascular morbidity and associated risk factors in Spanish patients with chronic inflammatory rheumatic diseases attending rheumatology clinics: baseline data of the CARMA Project","volume":"44","author":"Castaneda","year":"2015","journal-title":"Semin Arthritis Rheum."},{"key":"B9","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.atherosclerosis.2011.06.028","article-title":"ESC\/EAS Guidelines for the management of dyslipidaemias The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS)","volume":"217","author":"Catapano","year":"2011","journal-title":"Atherosclerosis."},{"key":"B10","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/0002-8703(91)90861-B","article-title":"Cardiovascular disease risk profiles","volume":"121","author":"Anderson","year":"1991","journal-title":"Am Heart J."},{"key":"B11","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1038\/nrrheum.2012.16","article-title":"Validated methods for assessment of subclinical atherosclerosis in rheumatology","volume":"8","author":"Kerekes","year":"2012","journal-title":"Nat Rev Rheumatol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.semarthrit.2014.03.004","article-title":"Risk of coronary artery disease in patients with idiopathic inflammatory myopathies: a systematic review and meta-analysis of observational studies","volume":"44","author":"Ungprasert","year":"2014","journal-title":"Semin Arthritis Rheum."},{"key":"B13","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1136\/annrheumdis-2017-211402","article-title":"Mortality in idiopathic inflammatory myopathy: results from a Swedish nationwide population-based cohort study","volume":"77","author":"Dobloug","year":"2018","journal-title":"Ann Rheum Dis."},{"key":"B14","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1093\/rheumatology\/kev336","article-title":"Risk of myocardial infarction and ischaemic stroke in adults with polymyositis and dermatomyositis: a general population-based study","volume":"55","author":"Rai","year":"2016","journal-title":"Rheumatology."},{"key":"B15","doi-asserted-by":"publisher","first-page":"e000291","DOI":"10.1136\/rmdopen-2016-000291","article-title":"Cardiac involvement in adult and juvenile idiopathic inflammatory myopathies","volume":"2","author":"Schwartz","year":"2016","journal-title":"RMD Open."},{"key":"B16","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1016\/S0195-668X(03)00114-3","article-title":"Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project","volume":"24","author":"Conroy","year":"2003","journal-title":"Eur Heart J."},{"key":"B17","doi-asserted-by":"publisher","first-page":"2439","DOI":"10.1093\/eurheartj\/ehab309","article-title":"SCORE2 risk prediction algorithms: new models to estimate 10-year risk of cardiovascular disease in Europe","volume":"42","year":"2021","journal-title":"Eur Heart J."},{"key":"B18","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1136\/annrheumdis-2016-209775","article-title":"EULAR recommendations for cardiovascular disease risk management in patients with rheumatoid arthritis and other forms of inflammatory joint disorders: 2015\/2016 update","volume":"76","author":"Agca","year":"2017","journal-title":"Ann Rheum Dis."},{"key":"B19","doi-asserted-by":"publisher","first-page":"1600","DOI":"10.1016\/j.jacc.2009.11.075","article-title":"Carotid intima-media thickness and presence or absence of plaque improves prediction of coronary heart disease risk: the ARIC (Atherosclerosis Risk In Communities) study","volume":"55","author":"Nambi","year":"2010","journal-title":"J Am Coll Cardiol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1001\/jama.300.2.197","article-title":"Ankle brachial index combined with Framingham Risk Score to predict cardiovascular events and mortality: a meta-analysis","volume":"300","author":"Ankle Brachial Index","year":"2008","journal-title":"JAMA."},{"key":"B21","doi-asserted-by":"publisher","first-page":"2588","DOI":"10.1093\/eurheartj\/ehl254","article-title":"Expert consensus document on arterial stiffness: methodological issues and clinical applications","volume":"27","author":"Laurent","year":"2006","journal-title":"Eur Heart J."},{"key":"B22","doi-asserted-by":"publisher","first-page":"2271","DOI":"10.1002\/art.40320","article-title":"2017 European League Against Rheumatism\/American College of Rheumatology classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups","volume":"69","author":"Lundberg","year":"2017","journal-title":"Arthritis Rheumatol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"i82","DOI":"10.1136\/annrheumdis-2011-200587","article-title":"New approaches to the assessment and treatment of the idiopathic inflammatory myopathies","volume":"71","author":"Miller","year":"2012","journal-title":"Ann Rheum Dis."},{"key":"B24","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1093\/rheumatology\/keg427","article-title":"International consensus outcome measures for patients with idiopathic inflammatory myopathies. Development and initial validation of myositis activity and damage indices in patients with adult onset disease","volume":"43","author":"Isenberg","year":"2004","journal-title":"Rheumatology."},{"key":"B25","doi-asserted-by":"publisher","first-page":"S118","DOI":"10.1002\/acr.20532","article-title":"Measures of adult and juvenile dermatomyositis, polymyositis, and inclusion body myositis: Physician and Patient\/Parent Global Activity, Manual Muscle Testing (MMT), Health Assessment Questionnaire (HAQ)\/Childhood Health Assessment Questionnaire (C-HAQ), Childhood Myositis Assessment Scale (CMAS), Myositis Disease Activity Assessment Tool (MDAAT), Disease Activity Score (DAS), Short Form 36 (SF-36), Child Health Questionnaire (CHQ), physician global damage, Myositis Damage Index (MDI), Quantitative Muscle Testing (QMT), Myositis Functional Index-2 (FI-2), Myositis Activities Profile (MAP), Inclusion Body Myositis Functional Rating Scale (IBMFRS), Cutaneous Dermatomyositis Disease Area and Severity Index (CDASI), Cutaneous Assessment Tool (CAT), Dermatomyositis Skin Severity Index (DSSI), Skindex, and Dermatology Life Quality Index (DLQI)","volume":"63","author":"Rider","year":"2011","journal-title":"Arthritis Care Res."},{"key":"B26","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1093\/rheumatology\/kez423","article-title":"How rheumatologists assess disability in the current era needs an overhaul: focus on the Health Assessment Questionnaire","volume":"59","author":"Bukhari","year":"2020","journal-title":"Rheumatology."},{"key":"B27","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1097\/00005650-199206000-00002","volume":"30","author":"Ware","year":"1992","journal-title":"Med Care."},{"key":"B28","doi-asserted-by":"publisher","first-page":"S79","DOI":"10.1093\/clinids\/18.Supplement_1.S79","article-title":"Measuring the functional impact of fatigue: initial validation of the fatigue impact scale","volume":"18","author":"Fisk","year":"1994","journal-title":"Clin Infect Dis."},{"key":"B29","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1891\/1061-3749.26.1.36","article-title":"A systematic review of studies using the multidimensional assessment of fatigue scale","volume":"26","author":"Belza","year":"2018","journal-title":"J Nurs Meas."},{"key":"B30","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1177\/0269215506069475","article-title":"A systematic review of the Human Activity Profile","volume":"21","author":"Davidson","year":"2007","journal-title":"Clin Rehabil."},{"key":"B31","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1007\/978-94-007-0753-5_156","article-title":"Beck depression inventory. In: Michalos AC, editor","volume-title":"Encyclopedia of Quality of Life and Well-Being Research","author":"Hubley","year":"2014"},{"key":"B32","doi-asserted-by":"publisher","first-page":"5060","DOI":"10.1093\/rheumatology\/keab397","article-title":"Sexual function in patients with idiopathic inflammatory myopathies: a cross-sectional study","volume":"60","author":"Hermankova","year":"2021","journal-title":"Rheumatology."},{"key":"B33","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1186\/s13075-021-02544-5","article-title":"The effect of a 24-week training focused on activities of daily living, muscle strengthening, and stability in idiopathic inflammatory myopathies: a monocentric controlled study with follow-up","volume":"23","author":"Spiritovic","year":"2021","journal-title":"Arthritis Res Ther."},{"key":"B34","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1016\/S0009-9120(01)00263-6","article-title":"The plasma parameter log (TG\/HDL-C) as an atherogenic index: correlation with lipoprotein particle size and esterification rate in apoB-lipoprotein-depleted plasma (FER(HDL))","volume":"34","author":"Dobiasova","year":"2001","journal-title":"Clin Biochem."},{"key":"B35","doi-asserted-by":"publisher","first-page":"1430","DOI":"10.1016\/j.clnu.2004.09.012","article-title":"Bioelectrical impedance analysis-part II: utilization in clinical practice","volume":"23","author":"Kyle","year":"2004","journal-title":"Clin Nutr."},{"key":"B36","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1210\/jc.2016-2422","article-title":"Long-term effect of adrenalectomy on cardiovascular remodeling in patients with pheochromocytoma","volume":"102","author":"Majtan","year":"2017","journal-title":"J Clin Endocrinol Metab."},{"key":"B37","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1161\/01.STR.24.9.1297","article-title":"Carotid artery intimal-medial thickness distribution in general populations as evaluated by B-mode ultrasound. ARIC Investigators","volume":"24","author":"Howard","year":"1993","journal-title":"Stroke."},{"key":"B38","doi-asserted-by":"publisher","first-page":"1953","DOI":"10.1097\/HJH.0000000000001940","article-title":"2018 ESC\/ESH Guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension: The Task Force for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension","volume":"36","author":"Williams","year":"2018","journal-title":"J Hypertens."},{"key":"B39","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1016\/j.echo.2020.04.021","article-title":"Recommendations for the assessment of carotid arterial plaque by ultrasound for the characterization of atherosclerosis and evaluation of cardiovascular risk: from the American Society of Echocardiography","volume":"33","author":"Johri","year":"2020","journal-title":"J Am Soc Echocardiogr."},{"key":"B40","doi-asserted-by":"publisher","first-page":"2020","DOI":"10.1161\/CIR.0b013e31822e80c3","article-title":"2011 ACCF\/AHA Focused Update of the Guideline for the Management of Patients With Peripheral Artery Disease (updating the 2005 guideline): a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines","volume":"58","author":"Rooke","year":"2011","journal-title":"J Am Coll Cardiol."},{"key":"B41","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/1476-7120-12-34","article-title":"Intima media thickness, pulse wave velocity, and flow mediated dilation","volume":"12","author":"Bruno","year":"2014","journal-title":"Cardiovasc Ultrasound."},{"key":"B42","doi-asserted-by":"publisher","first-page":"5170","DOI":"10.1097\/01.hjh.0000570340.25772.0c","article-title":"Blood pressure profile, catecholamine phenotype, and target organ damage in pheochromocytoma\/paraganglioma","volume":"104","author":"Petrak","year":"2019","journal-title":"J Clin Endocrinol Metab."},{"key":"B43","doi-asserted-by":"publisher","first-page":"2338","DOI":"10.1093\/eurheartj\/ehq165","article-title":"Determinants of pulse wave velocity in healthy people and in the presence of cardiovascular risk factors: 'establishing normal and reference values'","volume":"31","author":"Reference","year":"2010","journal-title":"Eur Heart J."},{"key":"B44","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1212\/01.wnl.0000303969.63165.34","article-title":"Carotid plaque, a subclinical precursor of vascular events: the Northern Manhattan Study","volume":"70","author":"Rundek","year":"2008","journal-title":"Neurology."},{"key":"B45","doi-asserted-by":"crossref","DOI":"10.1007\/s00330-021-08411-w","article-title":"Idiopathic inflammatory myopathies: CT characteristics of interstitial lung disease and their association(s) with myositis-specific autoantibodies","volume-title":"Eur Radiol","author":"Laporte","year":"2022"},{"key":"B46","doi-asserted-by":"publisher","first-page":"R7","DOI":"10.1186\/ar4135","article-title":"Atherosclerotic cardiovascular disease and dermatomyositis: an analysis of the Nationwide Inpatient Sample survey","volume":"15","author":"Linos","year":"2013","journal-title":"Arthritis Res Ther."},{"key":"B47","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1093\/rheumatology\/keaa525","article-title":"Possible misclassification of cardiovascular risk by SCORE in antisynthetase syndrome: results of the pilot multicenter study RI","volume":"60","author":"Triantafyllias","year":"2021","journal-title":"Rheumatology."},{"key":"B48","doi-asserted-by":"publisher","first-page":"875","DOI":"10.3899\/jrheum.150983","article-title":"Modified Framingham risk factor score for systemic lupus erythematosus","volume":"43","author":"Urowitz","year":"2016","journal-title":"J Rheumatol."},{"key":"B49","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1161\/CIRCULATIONAHA.107.699579","article-title":"General cardiovascular risk profile for use in primary care: the Framingham Heart Study","volume":"117","author":"D'Agostino","year":"2008","journal-title":"Circulation."},{"key":"B50","doi-asserted-by":"publisher","first-page":"e001364","DOI":"10.1136\/rmdopen-2020-001364","article-title":"Comparison of carotid artery ultrasound and Framingham risk score for discriminating coronary artery disease in patients with psoriatic arthritis","volume":"6","author":"Cheng","year":"2020","journal-title":"RMD Open."},{"key":"B51","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1007\/s10067-009-1118-y","article-title":"A comparative study of arterial stiffness, flow-mediated vasodilation of the brachial artery, and the thickness of the carotid artery intima-media in patients with systemic autoimmune diseases","volume":"28","author":"Soltesz","year":"2009","journal-title":"Clin Rheumatol."},{"key":"B52","doi-asserted-by":"publisher","first-page":"1635","DOI":"10.1007\/s10067-014-2561-y","article-title":"Decreased flow-mediated dilatation with increased arterial stiffness and thickness as early signs of atherosclerosis in polymyositis and dermatomyositis patients","volume":"33","author":"Vincze","year":"2014","journal-title":"Clin Rheumatol."},{"key":"B53","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1016\/j.jpeds.2011.05.015","article-title":"Clinical status and cardiovascular risk profile of adults with a history of juvenile dermatomyositis","volume":"159","author":"Eimer","year":"2011","journal-title":"J Pediatr."},{"key":"B54","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1002\/acr.22520","article-title":"Traditional cardiovascular risk factors and coronary artery calcification in adults with polymyositis and dermatomyositis: a Danish multicenter study","volume":"67","author":"Diederichsen","year":"2015","journal-title":"Arthritis Care Res."},{"key":"B55","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1111\/j.1468-3083.2011.04437.x","article-title":"Lipid profiles in untreated patients with dermatomyositis","volume":"27","author":"Wang","year":"2013","journal-title":"J Eur Acad Dermatol Venereol."},{"key":"B56","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1111\/j.1756-185X.2010.01470.x","article-title":"Idiopathic inflammatory myositis is associated with a high incidence of hypertension and diabetes mellitus","volume":"13","author":"Limaye","year":"2010","journal-title":"Int J Rheum Dis."},{"key":"B57","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1002\/acr.21879","article-title":"Analysis of metabolic syndrome in adult dermatomyositis with a focus on cardiovascular disease","volume":"65","author":"de Moraes","year":"2013","journal-title":"Arthritis Care Res."},{"key":"B58","doi-asserted-by":"publisher","first-page":"S21","DOI":"10.1016\/j.amjmed.2008.06.014","article-title":"Role of inflammation in atherosclerosis associated with rheumatoid arthritis","volume":"121","author":"Libby","year":"2008","journal-title":"Am J Med."},{"key":"B59","doi-asserted-by":"publisher","first-page":"1","DOI":"10.5935\/MedicalExpress.2017.02.05","article-title":"Could C-reactive protein and erythrocyte sedimentation rate support monitoring of dermatomyositis and polymyositis activity?","volume":"4","author":"Miossi","year":"2017","journal-title":"Medical Express."},{"key":"B60","doi-asserted-by":"publisher","first-page":"45","DOI":"10.3109\/10582452.2013.852151","article-title":"C-Reactive protein in idiopathic inflammatory myopathies","volume":"23","author":"Hanisch","year":"2015","journal-title":"Myopain."},{"key":"B61","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1002\/art.10794","article-title":"Interstitial lung disease in polymyositis and dermatomyositis","volume":"47","author":"Marie","year":"2002","journal-title":"Arthritis Rheum."},{"key":"B62","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1097\/CPM.0000000000000171","article-title":"The diagnosis and treatment of antisynthetase syndrome","volume":"23","author":"Witt","year":"2016","journal-title":"Clin Pulm Med."},{"key":"B63","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1007\/s11926-011-0176-8","article-title":"Antisynthetase syndrome","volume":"13","author":"Katzap","year":"2011","journal-title":"Curr Rheumatol Rep."},{"key":"B64","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1084\/jem.20020186","article-title":"Histidyl-tRNA synthetase and asparaginyl-tRNA synthetase, autoantigens in myositis, activate chemokine receptors on T lymphocytes and immature dendritic cells","volume":"196","author":"Howard","year":"2002","journal-title":"J Exp Med."},{"key":"B65","doi-asserted-by":"publisher","first-page":"104040","DOI":"10.1016\/j.mvr.2020.104040","article-title":"Secondary Raynaud's phenomenon is associated with microvascular peripheral endothelial dysfunction","volume":"132","author":"Taher","year":"2020","journal-title":"Microvasc Res."},{"key":"B66","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1160\/TH07-01-0036","article-title":"The specific role of chemokines in atherosclerosis","volume":"97","author":"Braunersreuther","year":"2007","journal-title":"Thromb Haemost."},{"key":"B67","doi-asserted-by":"publisher","first-page":"e75","DOI":"10.1161\/ATVBAHA.112.300857","article-title":"Leukocyte-specific CCL3 deficiency inhibits atherosclerotic lesion development by affecting neutrophil accumulation","volume":"33","author":"de Jager","year":"2013","journal-title":"Arterioscler Thromb Vasc Biol."},{"key":"B68","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1016\/j.yjmcc.2008.06.003","article-title":"CCL3 (MIP-1 alpha) levels are elevated during acute coronary syndromes and show strong prognostic power for future ischemic events","volume":"45","author":"de Jager","year":"2008","journal-title":"J Mol Cell Cardiol."},{"key":"B69","doi-asserted-by":"publisher","first-page":"e45804","DOI":"10.1371\/journal.pone.0045804","article-title":"Chemokines CCL3\/MIP1alpha, CCL5\/RANTES and CCL18\/PARC are independent risk predictors of short-term mortality in patients with acute coronary syndromes","volume":"7","author":"de Jager","year":"2012","journal-title":"PLoS ONE."},{"key":"B70","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.yjmcc.2009.03.012","article-title":"Macrophage inflammatory protein-1beta induced cell adhesion with increased intracellular reactive oxygen species","volume":"47","author":"Tatara","year":"2009","journal-title":"J Mol Cell Cardiol."},{"key":"B71","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1159\/000335886","article-title":"Macrophage inflammatory protein-1beta and fibrinogen are synergistic predictive markers of prognosis of intermediate coronary artery lesions","volume":"121","author":"Xu","year":"2012","journal-title":"Cardiology."},{"key":"B72","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1042\/CS20080581","article-title":"Role of MCP-1 in cardiovascular disease: molecular mechanisms and clinical implications","volume":"117","author":"Niu","year":"2009","journal-title":"Clin Sci."},{"key":"B73","doi-asserted-by":"publisher","first-page":"2147","DOI":"10.1161\/01.ATV.0000235691.84430.86","article-title":"Chemokines and incident coronary heart disease: results from the MONICA\/KORA Augsburg case-cohort study, 1984-2002","volume":"26","author":"Herder","year":"2006","journal-title":"Arterioscler Thromb Vasc Biol."},{"key":"B74","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1007\/s12265-016-9703-3","article-title":"CXCL10 is a circulating inflammatory marker in patients with advanced heart failure: a pilot study","volume":"9","author":"Altara","year":"2016","journal-title":"J Cardiovasc Transl Res."},{"key":"B75","first-page":"1335","article-title":"Increased Th9 cells and IL-9 levels accelerate disease progression in experimental atherosclerosis","volume":"9","author":"Li","year":"2017","journal-title":"Am J Transl Res."},{"key":"B76","doi-asserted-by":"publisher","first-page":"e72769","DOI":"10.1371\/journal.pone.0072769","article-title":"Increased systemic and local interleukin 9 levels in patients with carotid and coronary atherosclerosis","volume":"8","author":"Gregersen","year":"2013","journal-title":"PLoS ONE."},{"key":"B77","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1093\/rheumatology\/kem311","article-title":"Long-term exposure to medium-dose glucocorticoid therapy associates with hypertension in patients with rheumatoid arthritis","volume":"47","author":"Panoulas","year":"2008","journal-title":"Rheumatology."},{"key":"B78","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.jbspin.2010.02.040","article-title":"Cardiovascular risk induced by low-dose corticosteroids in rheumatoid arthritis: a systematic literature review","volume":"78","author":"Ruyssen-Witrand","year":"2011","journal-title":"Joint Bone Spine."},{"key":"B79","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/j.hfc.2013.10.003","article-title":"Cardiovascular comorbidity in rheumatic diseases: a focus on heart failure","volume":"10","author":"Wright","year":"2014","journal-title":"Heart Fail Clin."},{"key":"B80","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1056\/NEJMoa1809798","article-title":"Low-dose methotrexate for the prevention of atherosclerotic events","volume":"380","author":"Ridker","year":"2019","journal-title":"N Engl J Med."},{"key":"B81","doi-asserted-by":"publisher","first-page":"1943","DOI":"10.3899\/jrheum.090061","article-title":"Arterial events in persons with dermatomyositis and polymyositis","volume":"36","author":"Tisseverasinghe","year":"2009","journal-title":"J Rheumatol."},{"key":"B82","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1016\/j.rdc.2019.07.006","article-title":"Idiopathic inflammatory myopathies","volume":"45","author":"Vencovsky","year":"2019","journal-title":"Rheum Dis Clin North Am."},{"key":"B83","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1161\/CIRCULATIONAHA.120.046361","article-title":"Carotid intima-media thickness progression as surrogate marker for cardiovascular risk: meta-analysis of 119 clinical trials involving 100 667 patients","volume":"142","author":"Willeit","year":"2020","journal-title":"Circulation."}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2022.861419\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,5]],"date-time":"2022-05-05T10:56:35Z","timestamp":1651748195000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2022.861419\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,3]]},"references-count":83,"alternative-id":["10.3389\/fmed.2022.861419"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2022.861419","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,3]]},"article-number":"861419"}}